TRINITY BIOTECH PLC's ticker is TRIB and the CUSIP is 896438306. A total of 21 filers reported holding TRINITY BIOTECH PLC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $2,307,000 | +13.4% | 174,503 | -2.7% | 0.00% | 0.0% |
| Q2 2016 | $2,034,000 | -7.3% | 179,386 | -4.7% | 0.00% | -33.3% |
| Q1 2016 | $2,194,000 | -3.5% | 188,184 | -2.7% | 0.00% | 0.0% |
| Q4 2015 | $2,274,000 | -11.0% | 193,346 | -13.4% | 0.00% | 0.0% |
| Q3 2015 | $2,555,000 | -36.0% | 223,369 | +1.0% | 0.00% | -25.0% |
| Q2 2015 | $3,993,000 | -7.5% | 221,115 | -1.4% | 0.00% | -20.0% |
| Q1 2015 | $4,317,000 | -1.3% | 224,236 | -10.2% | 0.01% | 0.0% |
| Q4 2014 | $4,374,000 | -5.6% | 249,775 | -1.5% | 0.01% | -16.7% |
| Q3 2014 | $4,634,000 | -27.2% | 253,622 | -8.2% | 0.01% | -25.0% |
| Q2 2014 | $6,364,000 | -7.8% | 276,343 | -3.0% | 0.01% | 0.0% |
| Q1 2014 | $6,901,000 | +0.9% | 284,831 | +4.7% | 0.01% | -11.1% |
| Q4 2013 | $6,840,000 | +22.1% | 272,075 | +5.7% | 0.01% | +28.6% |
| Q3 2013 | $5,604,000 | +59.9% | 257,522 | +23.8% | 0.01% | +40.0% |
| Q2 2013 | $3,505,000 | – | 207,990 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACK Asset Management | 672,100 | $14,625,000 | 5.62% |
| GOLDMAN CAPITAL MANAGEMENT INC | 312,000 | $6,789,000 | 4.48% |
| Lyon Street Capital, LLC | 407,586 | $8,870,047,000 | 4.37% |
| GREAT POINT PARTNERS LLC | 189,071 | $4,114,000 | 2.85% |
| Adirondack Research & Management Inc. | 161,507 | $3,514,000 | 2.02% |
| Park West Asset Management LLC | 483,355 | $10,518,000 | 1.56% |
| Benchmark Capital Advisors | 56,954 | $1,239,000 | 0.89% |
| WOODMONT INVESTMENT COUNSEL LLC | 76,607 | $1,667,000 | 0.61% |
| SHEPHERD KAPLAN KROCHUK, LLC | 156,000 | $3,394,000 | 0.55% |
| HEARTLAND ADVISORS INC | 1,250,364 | $27,208,000 | 0.50% |